Clinical Trials Browser

Phase 2 × Terminated × Crohn Disease × Clear all

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT00584740 2015-03-31

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Phase 2 Terminated

59 enrolled 13 charts

Crohn Disease, Lymphoma, Follicular, Motor Activity

NCT00152841 2009-03-17

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis

Phase 2 Terminated

Colitis, Ulcerative, Crohn Disease, Lymphoma, Follicular